CCR5 and Hodgkins lymphoma: Previous reports demonstrated that the CCR5/CCL5 axis promotes a migratory and invasive phenotype in pancreatic cancer cells [53] and Hodgkin’s lymphoma [54] via tumour cell-intrinsic signalling of CCR5 on tumour cells.